NCT00419809View on ClinicalTrials.gov

SB-681323-Methotrexate Interaction Study

PHASE1CompletedINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions

Arthritis, Rheumatoid

Interventions

DRUG

SB-681323 oral tablets

Trial Locations (2)

2031

GSK Investigational Site, Randwick, Sydney

South Australia 5000

GSK Investigational Site, Adelaide

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY